Skip to main content
TipRanks
Go Ultimate75% OFF

HealthStream (HSTM) AI Stock Analysis

131 Followers
HSTM

HealthStream

(NASDAQ:HSTM)

Select Model
Rating:68Neutral
Price Target:$30.00â–²(8.58% Upside)
Action:reiterated
Date:11/04/26

The score is driven primarily by strong financial quality—especially a very low-debt balance sheet and steady revenue/margin profile—supported by constructive earnings-call updates with raised guidance and recurring-revenue strength. Offsetting these positives are a high valuation (P/E ~45.5) and only mixed technicals with weaker near-term trend despite longer-term support.

Positive Factors
Recurring revenue visibilityThe high subscription mix and multi-year contract structure provide meaningful revenue visibility and reduce reliance on repeated short-cycle selling. Large remaining performance obligations also support forward revenue conversion, helping sustain investment and planning over the next several quarters.
Negative Factors
Margin compressionRecent margin compression shows that labor, software, royalties, and hosting costs are absorbing part of the benefit from revenue growth. If these cost pressures persist, they could limit operating leverage and reduce the amount of incremental revenue that becomes durable earnings.

HealthStream Key Performance Indicators (KPIs)

Revenue by SegmentBreaks revenue down by product and service lines (for example, subscription software, professional services, and content licensing) to show which parts of the business drive growth and profits. A larger recurring subscription mix suggests more predictable cash flow and higher margins, while reliance on one-time or services revenue can mean lower margin potential and less revenue visibility. Shifts in these shares highlight where the company is gaining traction, facing competitive pressure, or exposed to customer concentration or healthcare spending cycles.

$0.00$20.00M$40.00M$60.00M$80.00MMar 21Jun 21Sep 21Dec 21Mar 22Jun 22Sep 22Dec 22Mar 23Jun 23Sep 23Dec 23Mar 24Jun 24Sep 24Dec 24Mar 25Jun 25Sep 25Dec 25Mar 26Jun 26Sep 26
Chart Insights

Subscription revenue is the durable growth engine—steady, sticky and expanding, supported by rising remaining performance obligations and management’s raised guidance—fueling cash flow and valuation stability. Professional Services is volatile and lumpy: declines through 2023 gave way to intermittent implementation spikes (recent quarter and large go‑lives), so service revenue gains may not be repeatable. Investors should credit subscription momentum but discount one‑time boosts (a $2M catch‑up) and watch planned H2 investments and expense growth that will temper near‑term margin upside.

Data provided by:The Fly

HealthStream (HSTM) vs. SPDR S&P 500 ETF (SPY)

-20%-10%0%10%20%30%40%50%HSTM+13.36%SPY+11.73%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
$846.89M
Dividend Yield
0.51%
Average Volume (3M)
212.66K
Price to Earnings (P/E)
39.7
Beta (1Y)
0.66
Revenue Growth
9.83%
EPS Growth
1.66%
Country
US
Employees
1,150
Sector
Healthcare
Sector Strength
51
Industry
Medical - Healthcare Information Services

HealthStream Business Overview & Revenue Model

Company Description

HealthStream, Inc., established in 1990 and headquartered in Nashville, Tennessee, delivers specialized workforce and provider solutions to healthcare organizations throughout the United States. Its operations are divided into two primary segments: W...

How the Company Makes Money

HealthStream primarily generates revenue by selling subscriptions to its SaaS platforms and related solutions to healthcare organizations. A major revenue stream is recurring subscription fees for access to its learning, workforce, and credentialing/...

HealthStream Earnings Call Summary

Earnings Call Date:Nov 02, 2026(Q3-2026)|% Change Since:-20.00%|Next Earnings Date:Feb 22, 2027
Earnings Call SentimentPositive

The call was predominantly positive, supported by raised full-year guidance, strong revenue and cash-flow growth, a strengthened balance sheet, continued investment in the hStream platform and sales organization, and encouraging adoption of integrated suites and career-network products. The main challenges were lower operating income, net income, and margins; declining legacy-product revenue; near-term hosting-migration and seasonal expense pressure; and acquisitions that are performing below original expectations. Overall, the number and strength of the positive developments significantly outweighed the disclosed challenges.

Positive Updates

Raised Full-Year 2026 Guidance
HealthStream raised its full-year guidance for the second consecutive quarter. Revenue is now expected to be $331 million-$333 million, net income $21.8 million-$22.4 million, and adjusted EBITDA $77 million-$78 million, with each range improving over the guidance shared in August.

Negative Updates

Declines in Operating Income, Net Income, and EPS
Third-quarter operating income was $6.6 million, down 13% year-over-year. Net income was $5.4 million, down 11.7%, and EPS declined to $0.18 from $0.20.

Company Guidance

For updated full-year guidance, HealthStream expects revenues of $331 million-$333 million, net income of $21.8 million-$22.4 million, adjusted EBITDA of $77 million-$78 million, and capital expenditures of $31 million-$34 million. The updated revenue guidance range implies that fourth quarter revenue growth will be in the 4%-6% range, and adjusted EBITDA margin is expected to approximate 21% for the fourth quarter. The company expects lower revenue growth rates in the fourth quarter, due in part to lower inorganic growth rates, and said fourth quarter forecasts assume higher operating expenses, including labor costs, significantly more trade shows, and professional services associated with the cloud hosting consolidation initiative. These guidance expectations do not include the impact of any acquisitions or dispositions that we may complete during the year, gains or losses from changes in fair value of non-marketable equity investments or contingent consideration, or impairment of long-lived assets that we may complete during the year.

HealthStream Financial Statement Overview

Summary

Solid fundamentals supported by steady multi-year revenue growth, durable ~65% gross margins, and improving EBITDA margin into the low-20% range. The balance sheet is a standout with minimal leverage and growing equity, but the score is tempered by modest net margins (~6%) and a recent step-down/volatility in free cash flow versus prior periods, indicating less consistent earnings-to-cash conversion.

Income Statement

74Positive

Balance Sheet

88Very Positive

Cash Flow

63Positive
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue327.95M304.06M291.65M279.06M266.83M256.71M
Gross Profit212.32M196.85M193.71M184.04M175.68M165.68M
EBITDA71.00M66.70M66.05M59.59M53.53M44.58M
Net Income20.49M18.34M20.01M15.21M12.09M5.84M
Balance Sheet
Total Assets565.85M520.37M510.77M499.94M497.74M486.75M
Cash, Cash Equivalents and Short-Term Investments115.16M57.00M97.22M71.13M53.91M51.95M
Total Debt12.78M14.68M20.17M20.25M23.32M29.11M
Total Liabilities163.91M166.35M151.41M159.19M163.68M147.73M
Stockholders Equity401.94M354.02M359.36M340.75M334.06M339.02M
Cash Flow
Free Cash Flow40.91M59.63M29.52M61.77M49.42M38.97M
Operating Cash Flow71.15M63.32M57.66M63.97M51.19M42.38M
Investing Cash Flow-84.45M-50.35M-33.97M-56.60M-28.39M-25.72M
Financing Cash Flow18.73M-36.27M-4.52M-13.04M-23.70M-6.21M

HealthStream Technical Analysis

Technical Analysis SentimentNegative
Last Price27.63

Price Trends

50DMA31.03Negative
100DMA29.72Negative
200DMA25.95Positive

Market Momentum

MACD-1.11Positive
RSI29.33Positive
STOCH3.88Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HSTM, the sentiment is Negative. The current price of 27.63 is below the 20-day moving average (MA) of 31.71, below the 50-day MA of 31.03, and above the 200-day MA of 25.95, indicating a neutral trend. The MACD of -1.11 indicates Positive momentum. The RSI at 29.33 is Positive, neither overbought nor oversold. The STOCH value of 3.88 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HSTM.

HealthStream Risk Analysis

HealthStream disclosed 38 risk factors in its most recent earnings report. HealthStream reported the most risks in the "Finance & Corporate" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

3 New Risks
1.The development and use of AI or the failure to adequately or appropriately develop and use AI, including generative AI and agentic AI, may result in reputational harm, liability, and adverse financial results, and could impact our value proposition.Q4, 2025
2.We have been adversely impacted, and may continue to be adversely impacted, by unfavorable conditions and uncertainty in the healthcare industry and the U.S. economy more generally.Q4, 2025
3.We have been impacted, and may continue to be adversely impacted, by unfavorable conditions and uncertainty impacting the healthcare industry and the U.S. economy more generally.Q2, 2025

HealthStream Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

HSTM against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
SPOKSPOK78Outperform$245.93M13.1113.12%10.64%-3.32%10.97%
PHRPHR69Neutral$795.75M73.813.01%―12.93%―
HSTMHSTM68Neutral$847.92M39.755.60%0.51%9.83%1.66%
DHDH61Neutral$183.02M-0.84-87.69%―-6.18%10.48%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
HCATHCAT51Neutral$105.09M-0.49-128.24%―-13.88%-78.38%
NRCNRC49Neutral$558.76M86.57103.40%2.43%3.37%-59.57%

* Healthcare Sector Average

Performance Comparison

-50%0%50%HSTMSPOKNRCPHRHCATDHDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
HSTM and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
HSTMHealthstream27.633.1512.85%
SPOKSpok Holdings11.580.040.36%
NRCNational Research25.8910.1164.11%
PHRPhreesia12.56-6.63-34.55%
HCATHealth Catalyst1.37-0.74-35.07%
DHDefinitive Healthcare Corp. Class A1.31-1.27-49.22%

HealthStream Corporate Events

DividendsFinancial DisclosuresPrivate Placements and Financing

HealthStream Reports Third-Quarter Results and Declares Dividend

Neutral
Nov 2, 2026

On November 2, 2026, HealthStream, a healthcare technology platform company for clinical workforce solutions, reported third-quarter results for the period ended September 30, 2026, including revenue of $83.3 million, up 8.9% year over year. Operatin...

Business Operations and StrategyPrivate Placements and Financing

HealthStream Raises Growth Capital in Governance-Conscious Placement

Positive
Sep 15, 2026

On September 14, 2026, HealthStream completed a private placement in which WJRJJ Ventures, LLC acquired a total of 1.5 million shares of its common stock at $29.50 per share, including approximately $40 million of newly issued shares from the company...

Business Operations and StrategyPrivate Placements and Financing

HealthStream Amends Revolving Credit Facility to Extend Liquidity

Positive
Sep 14, 2026

On September 10, 2026, HealthStream, Inc. amended its existing revolving credit facility by entering into a Second Amendment to its Amended and Restated Revolving Credit Agreement, maintaining a $50 million unsecured revolving line with a $5 million...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 04, 2026